10-K.Info (Beta Test) Courtesy of Short Sands, LLC | ||||||||||||||
| ||||||||||||||
|
10-K.Info (Beta Test) Courtesy of Short Sands, LLC | |||
CVS HEALTH CORP | |||
Ticker: CVS Fiscal Year: 2013 | |||
Consolidated Statements of Cash Flows | |||
Period Ending Dec 31, 2013 10-K (Filed: Feb 11, 2014) | |||
| (In Millions, except shares in actual) | |||
| 12 Months Ended | 12 Months Ended | 12 Months Ended | |
| Dec 31, 2013 | Dec 31, 2012 | Dec 31, 2011 | |
| Cash flows from operating activities: | |||
| Cash receipts from customers | $ 114,993 | 113,205 | 97,688 |
| Cash paid for inventory and prescriptions dispensed by retail network pharmacies | (91,178) | (90,032) | (75,148) |
| Cash paid to other suppliers and employees | (14,295) | (13,643) | (13,635) |
| Interest received | 8 | 4 | 4 |
| Interest paid | (534) | (581) | (647) |
| Income taxes paid | (3,211) | (2,282) | (2,406) |
| Net cash provided by operating activities | 5,783 | 6,671 | 5,856 |
| Cash flows from investing activities: | |||
| Purchases of property and equipment | (1,984) | (2,030) | (1,872) |
| Proceeds from sale-leaseback transactions | 600 | 529 | 592 |
| Proceeds from sale of property and equipment and other assets | 54 | 23 | 4 |
| Acquisitions (net of cash acquired) and other investments | (415) | (378) | (1,441) |
| Purchase of available-for-sale investments | (226) | 0 | (3) |
| Maturity of available-for-sale investments | 136 | 0 | 60 |
| Proceeds from sale of subsidiary | 0 | 7 | 250 |
| Net cash used in investing activities | (1,835) | (1,849) | (2,410) |
| Cash flows from financing activities: | |||
| Increase (decrease) in short-term debt | (690) | (60) | 450 |
| Proceeds from issuance of long-term debt | 3,964 | 1,239 | 1,463 |
| Repayments of long-term debt | 0 | (1,718) | (2,122) |
| Purchase of noncontrolling interest in subsidiary | 0 | (26) | 0 |
| Dividends paid | (1,097) | (829) | (674) |
| Derivative settlements | 0 | 0 | (19) |
| Proceeds from exercise of stock options | 500 | 836 | 431 |
| Excess tax benefits from stock-based compensation | 62 | 28 | 21 |
| Repurchase of common stock | (3,976) | (4,330) | (3,001) |
| Other | 0 | 0 | (9) |
| Net cash used in financing activities | (1,237) | (4,860) | (3,460) |
| Effect of exchange rate changes on cash and cash equivalents | 3 | 0 | 0 |
| Net increase (decrease) in cash and cash equivalents | 2,714 | (38) | (14) |
| Cash and cash equivalents at the beginning of the year | 1,375 | 1,413 | |
| Cash and cash equivalents at the end of the year | 4,089 | 1,375 | 1,413 |
| Reconciliation of net income to net cash provided by operating activities: | |||
| Net income | 4,592 | 3,862 | 3,458 |
| Adjustments required to reconcile net income to net cash provided by operating activities: | |||
| Depreciation and amortization | 1,870 | 1,753 | 1,568 |
| Stock-based compensation | 141 | 132 | 135 |
| Loss on early extinguishment of debt | 0 | 348 | 0 |
| Gain on sale of subsidiary | 0 | 0 | (53) |
| Deferred income taxes and other noncash items | (86) | (111) | 144 |
| Change in operating assets and liabilities, net of effects from acquisitions: | |||
| Accounts receivable, net | (2,210) | (387) | (748) |
| Inventories | 12 | (853) | 586 |
| Other current assets | 105 | 3 | (420) |
| Other assets | (135) | (99) | (49) |
| Accounts payable and claims and discounts payable | 1,024 | 1,147 | 1,128 |
| Accrued expenses | 471 | 766 | 105 |
| Other long-term liabilities | (1) | 110 | 2 |
| Net cash provided by operating activities | 5,783 | 6,671 | 5,856 |
| External Links | |
| CVS HEALTH CORP (CVS) Fiscal Year 2013 | |
| Statements of 10-K in Excel | https://www.sec.gov/.../Financial.xlxs |
| Complete 10-K in HTML | https://www.sec.gov/.../10-K.html |
| Complete 10-K in XBRL | https://www.sec.gov/.../10-K-xbrl.zip |